Vodafone Idea is currently trading at Rs. 10.55, up by 0.57 points or 5.71% from its previous closing of Rs. 9.98 on the BSE. The scrip opened at Rs. 10.39 and has touched a high and low of Rs. 10.88 and Rs. 10.23 respectively. So far 108604342 shares were traded on the counter. The BSE … Read more
RattanIndia backed Revolt has opened its dealership in Vizag. This is their first store in the Andhra Pradesh region and 15th retail store across India. With the rising petrol prices and an aim to fulfill the consumer demand, the company has plans to expand its sales network and strengthen retail presence further by entering 60 … Read more
KDDL has acquired 1,91,000 (19.10%) equity shares of Rs 10 each of ‘Kamla Tesio Dials’ (KTDL), an associate Company. The acquisition will help the company to capture additional market share of customers in Domestic Market. Post the above acquisition, shareholding of KDDL in KTDL has increased from 30.00% to 49.10%. Further, the company proposes to … Read more
HFCL along with its subsidiary, HTL, has received the Purchase Orders (PO) aggregating to Rs 412.90 crore, from one of the leading Private Telecom Operators of the Country for supply of Optical Fibre Cables (OFC). The orders are expected to be completed by March, 2022. HFCL is a leading telecom infrastructure developer, system integrator and … Read more
Somany Ceramics is currently trading at Rs. 860.40, up by 9.45 points or 1.11% from its previous closing of Rs. 854.40 on the BSE. The scrip opened at Rs. 943.95 and has touched a high and low of Rs. 943.95 and Rs. 850.00 respectively. So far 737 shares were traded on the counter. The BSE … Read more
Amber Enterprises India is currently trading at Rs. 3441.05, up by 49.30 points or 1.45% from its previous closing of Rs. 3391.75 on the BSE. The scrip opened at Rs. 3460.00 and has touched a high and low of Rs. 3480.00 and Rs. 3382.15 respectively. So far 616 shares were traded on the counter. The … Read more
HealthCare Global Enterprises (HCG) has acquired additional 60.9% stake in Suchirayu Healthcare Solutions (Suchirayu), Hubli, thereby becoming a majority stake owner from its existing 17.7% to 78.6%. Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds. HCG has operated and … Read more
Zydus Cadila has received final approval from the U.S. Food and Drug Administration (USFDA) to market Decitabine for Injection in the strength of 50 mg/vial Single-Dose Vial (USRLD: Dacogen). Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer. The drug will be manufactured at the group’s injectables manufacturing facility … Read more